您即将离开沛嘉医疗中文官网。
您刚才点击了进入另一网站的链接。如果继续,您可能会进入由第三方运行的网站。 我们不负责对非沛嘉医疗中文官网上的内容进行审核与管控,亦不会对您在非沛嘉医疗中文网上的任何商业交易或事物承担任何责任。您使用其他网站时,必须遵循该网站的使用条款及隐私声明。 其他网站上的部分产品和信息可能并未在您所在地区或国家获得批准。
取消
继续
Brief News on Innovation
Company News Brief News on Innovation
TaurusAtlas Pro, THE SECOND-GENERATION BALLOON DILATATION CATHETER, HAS BEEN APPROVED BY THE NMPA
2024-02-01 09:41:30

The registration application of TaurusAtlas Pro, the second-generation balloon dilatation catheter independently developed by Peijia Medical, was approved by the NMPA on January 30, 2024. 

Based on its previous generation, TaurusAtlas Pro has optimized product performance and added new sizes to cover dilatation needs from 10mm to 28mm and adapt to a variety of TAVR procedures. The superior performance of the procedural accessory will help the physician to further enhance procedure safety, optimize the procedure process and hence improve operational efficiency.


Top